Gloshell
成分词典
成分列表

成分词典

OCTADECENE

Octadec-1-ene is an octadecene with unsaturation at C-1.

分子结构

产品中实际含有多少

暂无产品标示该成分含量。

含该成分的产品中，11 款将其列在 1% 线之前，0 款列在之后（通常不超过 1%）。

含有此成分的产品

已确认 11 款中的 11 款 · 按含量充足程度排序

定义

Octadec-1-ene is an octadecene with unsaturation at C-1.

来源: PubChem

化妆品中的作用

调节黏度VISCOSITY CONTROLLING溶解其他成分的基质SOLVENT

安全与法规参考

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息（环境公团）

详细资料——标示名称、识别编号、物性、试验记录、文献

官方标示名称和定义

日本化妆品工业联合会标示名称 オクタデセン: 本品は、次の化学式で表される炭化水素である。

来源: 日本化妆品工业联合会标示名称

别名和识别信息

OCTADECENEINCI옥타데센韩国标示名称（食药处标准名）オクタデセン日本标示名称
CAS No.化学物质登记号
112-88-9
CAS No.化学物质登记号
27070-58-2
EC No.欧盟化学品目录编号
214-012-9
EC No.欧盟化学品目录编号
248-205-6
DTXSID美国EPA化学品编号
DTXSID0040250

实测物性

性状
Liquid · Melting point = 17.5 deg C, [ChemIDplus] Colorless liquid, mp = 18.3 deg C, [OECD SIDS: Higher Olefins - 2004]
熔点/凝固点
17 ℃
闪点
93.3~148 ℃
正辛醇/水分配系数（Kow）
7.74
分子量
252.48

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

来源: PubChem · 韩国安全保健公团 安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 12 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

  • Viscosity modifier3
  • Solvent2
  • Surfactant (surface active agent)2
  • Intermediate1
  • Sizing agent1
  • Processing aids not otherwise specified1
  • Surface modifier1
  • Lubricating agent1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 14 项、眼部试验 5 项。

归类为刺激性高5 项归类为中等3 项归类为低32 项

各项试验结论不一（最多的结论占 13%），因此不能断定该成分有刺激性。 这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 19 项试验
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to

来源: 美国EPA CompTox

相关文献

关联数据库 15

社区

发帖提问后，Gloshell AI 会先回答，其他成员接着回复。